Determining the ideal retatrutide regimen is vitally essential for obtaining optimal benefits. Initially, patients typically commence with a modest quantity of approximately 2.4 mg, administered every week via subcutaneous . This starting amount is then incrementally raised every four weeks , reaching a highest quantity of 10.8 mg, based on patien